메뉴 건너뛰기




Volumn 16, Issue 7, 2014, Pages

An integrated approach for the systematic evaluation of polymeric nanoparticles in healthy and diseased organisms

Author keywords

Imaging; Integrated platform; Nanomedicine; Nanoparticle characterization; Polymeric nanoparticles; Theranostics

Indexed keywords

BODY FLUIDS; CELL CULTURE; CELLS; CHARACTERIZATION; DISEASES; ESTERS; IMAGING TECHNIQUES; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; POLYMERS;

EID: 84902023330     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2481-4     Document Type: Article
Times cited : (11)

References (34)
  • 2
    • 68949206606 scopus 로고    scopus 로고
    • The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide
    • doi:10.1111/j.1471-4159.2009.06228.x
    • Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 110(5):1445-1456. doi:10.1111/j.1471-4159.2009.06228.x
    • (2009) J Neurochem , vol.110 , Issue.5 , pp. 1445-1456
    • Albani, D.1    Polito, L.2    Batelli, S.3    De Mauro, S.4    Fracasso, C.5    Martelli, G.6    Colombo, L.7    Manzoni, C.8    Salmona, M.9    Caccia, S.10    Negro, A.11    Forloni, G.12
  • 3
    • 84861669644 scopus 로고    scopus 로고
    • Doxil® â€" The first FDA-approved nano-drug: Lessons learned
    • doi:10.1016/j.jconrel.2012.03.020
    • Barenholz Y (2012) Doxil® â€" The first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117-134. doi:10.1016/j.jconrel.2012.03.020
    • (2012) J Control Release , vol.160 , Issue.2 , pp. 117-134
    • Barenholz, Y.1
  • 6
    • 84871700095 scopus 로고    scopus 로고
    • Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes
    • doi:10.3390/s121216420
    • Canovi M, Lucchetti J, Stravalaci M, Re F, Moscatelli D, Bigini P, Salmona M, Gobbi M (2013) Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. Sensors (Basel) 12(12):16420-16432. doi:10.3390/s121216420
    • (2013) Sensors (Basel) , vol.12 , Issue.12 , pp. 16420-16432
    • Canovi, M.1    Lucchetti, J.2    Stravalaci, M.3    Re, F.4    Moscatelli, D.5    Bigini, P.6    Salmona, M.7    Gobbi, M.8
  • 7
    • 84878630525 scopus 로고    scopus 로고
    • Nanoparticle characterization: State of the art, challenges, and emerging technologies
    • doi:10.1021/mp300697h
    • Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y (2013) Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm 10(6):2093-2110. doi:10.1021/mp300697h
    • (2013) Mol Pharm , vol.10 , Issue.6 , pp. 2093-2110
    • Cho, E.J.1    Holback, H.2    Liu, K.C.3    Abouelmagd, S.A.4    Park, J.5    Yeo, Y.6
  • 11
    • 84888865755 scopus 로고    scopus 로고
    • Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment
    • doi:10.1021/nn4047925
    • Deng ZJ, Morton SW, Ben-Akiva E, Dreaden EC, Shopsowitz KE, Hammond PT (2013) Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7(11):9571-9584. doi:10.1021/nn4047925
    • (2013) ACS Nano , vol.7 , Issue.11 , pp. 9571-9584
    • Deng, Z.J.1    Morton, S.W.2    Ben-Akiva, E.3    Dreaden, E.C.4    Shopsowitz, K.E.5    Hammond, P.T.6
  • 12
    • 84887070003 scopus 로고    scopus 로고
    • Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
    • doi:10.1016/j.jconrel.2013.05.025
    • Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456-466. doi:10.1016/j.jconrel.2013.05.025
    • (2013) J Control Release , vol.172 , Issue.2 , pp. 456-466
    • Dobrovolskaia, M.A.1    McNeil, S.E.2
  • 16
    • 84876486923 scopus 로고    scopus 로고
    • CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice
    • doi:10.1002/glia.22474
    • Fumagalli S, Perego C, Ortolano F, De Simoni MG (2013) CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61(6):827-842. doi:10.1002/glia.22474
    • (2013) Glia , vol.61 , Issue.6 , pp. 827-842
    • Fumagalli, S.1    Perego, C.2    Ortolano, F.3    De Simoni, M.G.4
  • 18
    • 79951898882 scopus 로고    scopus 로고
    • Interactions of nanoparticles with plasma proteins: Implication on clearance and toxicity of drug delivery systems
    • doi:10.1517/17425247.2011.554818
    • Karmali PP, Simberg D (2011) Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 8(3):343-357. doi:10.1517/17425247.2011.554818
    • (2011) Expert Opin Drug Deliv , vol.8 , Issue.3 , pp. 343-357
    • Karmali, P.P.1    Simberg, D.2
  • 19
    • 84856621061 scopus 로고    scopus 로고
    • Expert opinion: Responsive polymer nanoparticles in cancer therapy
    • doi:10.1016/j.ejpb.2011.08.004
    • Liechty WB, Peppas NA (2012) Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm 80(2):241-246. doi:10.1016/j.ejpb.2011.08.004
    • (2012) Eur J Pharm Biopharm , vol.80 , Issue.2 , pp. 241-246
    • Liechty, W.B.1    Peppas, N.A.2
  • 20
    • 84878104912 scopus 로고    scopus 로고
    • Paclitaxel nano-delivery systems: A comprehensive review
    • doi:10.4172/2157-7439.1000164
    • Ma P, Mumper RJ (2013) Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol 4(2):1000164. doi:10.4172/2157-7439.1000164
    • (2013) J Nanomed Nanotechnol , vol.4 , Issue.2 , pp. 1000164
    • Ma, P.1    Mumper, R.J.2
  • 21
    • 84888419295 scopus 로고    scopus 로고
    • Influence of nanoparticle shape, size, and surface functionalization on cellular uptake
    • Ma N, Ma C, Li C, Wang T, Tang Y, Wang H, Moul X, Chen Z, Hel N (2013) Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J Nanosci Nanotechnol 13(10):6485-6498
    • (2013) J Nanosci Nanotechnol , vol.13 , Issue.10 , pp. 6485-6498
    • Ma, N.1    Ma, C.2    Li, C.3    Wang, T.4    Tang, Y.5    Wang, H.6    Moul, X.7    Chen, Z.8    Hel, N.9
  • 22
    • 70350292588 scopus 로고    scopus 로고
    • Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer
    • doi:10.1016/j.tips.2009.08.004
    • Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11):592-599. doi:10.1016/j.tips.2009.08.004
    • (2009) Trends Pharmacol Sci , vol.30 , Issue.11 , pp. 592-599
    • Malam, Y.1    Loizidou, M.2    Seifalian, A.M.3
  • 23
    • 84878170578 scopus 로고    scopus 로고
    • Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
    • doi:10.2147/IJN.S43683
    • Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash S (2013) Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomed 8:2041-2052. doi:10.2147/IJN. S43683
    • (2013) Int J Nanomed , vol.8 , pp. 2041-2052
    • Malhotra, M.1    Tomaro-Duchesneau, C.2    Saha, S.3    Kahouli, I.4    Prakash, S.5
  • 24
    • 57249084773 scopus 로고    scopus 로고
    • Polymeric micellar delivery systems in oncology
    • doi:10.1093/jjco/hyn116
    • Matsumura Y (2008) Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol 38(12):793-802. doi:10.1093/jjco/hyn116
    • (2008) Jpn J Clin Oncol , vol.38 , Issue.12 , pp. 793-802
    • Matsumura, Y.1
  • 25
    • 84873853768 scopus 로고    scopus 로고
    • Biomolecular coronas provide the biological identity of nanosized materials
    • doi:10.1038/nnano.2012.207
    • Monopoli MP, Aberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7(12):779-786. doi:10.1038/nnano.2012.207
    • (2012) Nat Nanotechnol , vol.7 , Issue.12 , pp. 779-786
    • Monopoli, M.P.1    Aberg, C.2    Salvati, A.3    Dawson, K.A.4
  • 26
    • 84865264928 scopus 로고    scopus 로고
    • Combinatorial nanoparticles for cancer diagnosis and therapy
    • CMC-EPUB-20120607-22 [pii]
    • Mukerjee A, Ranjan AP, Vishwanatha JK (2012) Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem 19(22):3714-3721 CMC-EPUB-20120607-22 [pii]
    • (2012) Curr Med Chem , vol.19 , Issue.22 , pp. 3714-3721
    • Mukerjee, A.1    Ranjan, A.P.2    Vishwanatha, J.K.3
  • 27
    • 84890996933 scopus 로고    scopus 로고
    • Nanomaterials in combating cancer: Therapeutic applications and developments
    • doi:10.1016/j.nano.2013.07.001
    • Nazir S, Hussain T, Ayub A, Rashid U, Macrobert AJ (2014) Nanomaterials in combating cancer: therapeutic applications and developments. Nanomedicine 10(1):19-34. doi:10.1016/j.nano.2013.07.001
    • (2014) Nanomedicine , vol.10 , Issue.1 , pp. 19-34
    • Nazir, S.1    Hussain, T.2    Ayub, A.3    Rashid, U.4    Macrobert, A.J.5
  • 28
    • 79151476662 scopus 로고    scopus 로고
    • Triple negative breast cancer: Unmet medical needs
    • doi:10.1007/s10549-010-1293-1
    • Pal SK, Childs BH, Pegram M (2011) Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125(3):627-636. doi:10.1007/s10549-010- 1293-1
    • (2011) Breast Cancer Res Treat , vol.125 , Issue.3 , pp. 627-636
    • Pal, S.K.1    Childs, B.H.2    Pegram, M.3
  • 29
    • 84855824016 scopus 로고    scopus 로고
    • Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging
    • doi:10.1016/j.nano.2011.05.016
    • Parveen S, Misra R, Sahoo SK (2011) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8(2):147-166. doi:10.1016/j.nano.2011.05.016
    • (2011) Nanomedicine , vol.8 , Issue.2 , pp. 147-166
    • Parveen, S.1    Misra, R.2    Sahoo, S.K.3
  • 30
    • 36849067019 scopus 로고    scopus 로고
    • Nanocarriers as an emerging platform for cancer therapy
    • DOI 10.1038/nnano.2007.387, PII NNANO2007387
    • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751-760. doi:10.1038/nnano.2007.387 (Pubitemid 350223348)
    • (2007) Nature Nanotechnology , vol.2 , Issue.12 , pp. 751-760
    • Peer, D.1    Karp, J.M.2    Hong, S.3    Farokhzad, O.C.4    Margalit, R.5    Langer, R.6
  • 31
    • 77955175216 scopus 로고    scopus 로고
    • Strategies in the design of nanoparticles for therapeutic applications
    • doi:10.1038/nrd2591
    • Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615-627. doi:10.1038/nrd2591
    • (2010) Nat Rev Drug Discov , vol.9 , Issue.8 , pp. 615-627
    • Petros, R.A.1    DeSimone, J.M.2
  • 32
    • 33244478081 scopus 로고    scopus 로고
    • Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion
    • doi:10.1371/journal.pbio.0040022
    • Schaffer CB, Friedman B, Nishimura N, Schroeder LF, Tsai PS, Ebner FF, Lyden PD, Kleinfeld D (2006) Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion. PLoS Biol 4(2):e22. doi:10.1371/journal.pbio.0040022
    • (2006) PLoS Biol , vol.4 , Issue.2
    • Schaffer, C.B.1    Friedman, B.2    Nishimura, N.3    Schroeder, L.F.4    Tsai, P.S.5    Ebner, F.F.6    Lyden, P.D.7    Kleinfeld, D.8
  • 33
    • 84855961163 scopus 로고    scopus 로고
    • Nanoparticle delivery of cancer drugs
    • doi:10.1146/annurev-med-040210-162544
    • Wang AZ, Langer R, Farokhzad OC (2011) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185-198. doi:10.1146/annurev-med-040210-162544
    • (2011) Annu Rev Med , vol.63 , pp. 185-198
    • Wang, A.Z.1    Langer, R.2    Farokhzad, O.C.3
  • 34
    • 84890834106 scopus 로고    scopus 로고
    • Nanomedicine: De novo design of nanodrugs
    • doi:10.1039/c3nr04535h
    • Yang Z, Kang SG, Zhou R (2013) Nanomedicine: de novo design of nanodrugs. Nanoscale 6(2):663-677. doi:10.1039/c3nr04535h
    • (2013) Nanoscale , vol.6 , Issue.2 , pp. 663-677
    • Yang, Z.1    Kang, S.G.2    Zhou, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.